NCT04054557View on ClinicalTrials.gov

Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence

NAActive, not recruitingINTERVENTIONAL
Enrollment

305

Participants

Timeline

Start Date

July 31, 2019

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Stage 0 Breast Cancer AJCC v6 and v7Stage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7Stage IB Breast Cancer AJCC v7Stage II Breast Cancer AJCC v6 and v7Stage IIA Breast Cancer AJCC v6 and v7Stage IIB Breast Cancer AJCC v6 and v7Stage IIIA Breast Cancer AJCC v7Stage IIIB Breast Cancer AJCC v7Stage IIIC Breast Cancer AJCC v7Stage III Breast Cancer AJCC v7
Interventions
OTHER

Telemedicine

Participate in virtual visits with oncologist

OTHER

Best Practice

Receive 4 in-office visits with oncologist

OTHER

Questionnaire Administration

Ancillary studies

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Survey Administration

Complete electronic survey

BEHAVIORAL

Behavioral Intervention

Use smart pill bottle

OTHER

Educational Intervention

Receives time-specific reminders and messages

Trial Locations (5)

19090

Jefferson Health - Asplundh Cancer Pavilion, Willow Grove

19107

Thomas Jefefrson University, Philadelphia

19114

Jefferson Health - Northeast, Torresdale

19148

Methodist Hospital, Philadelphia

08080

Jefferson Health - South Jersey, Washington Township

All Listed Sponsors
lead

Thomas Jefferson University

OTHER

NCT04054557 - Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence | Biotech Hunter | Biotech Hunter